News

Cancer patients should be aware of scientific misinformation

5 November 2019

Phase I Study of Fluvastatin/Celecoxib Combination in Children with Relapsing or Refractory Low or High Grade Glioma - First Results

Presented at SIOP 2019

26 October 2019

Lung Cancer Survival Gains: Contributions of Academia and Industry

Bishal Gyawali, Gauthier Bouche, Pan Pantziarka, Aaron S. Kesselheim, Ameet Sarpatwari (2019) - Lung Cancer Survival Gains: Contributions of Academia and Industry. The Journal of Law, Medicine & Ethics, 47 (2019): 465-467. DOI: 10.1177/1073110519876182

30 September 2019

Pioglitazone and clarithromycin combined with metronomic chemotherapy vs. nivolumab in patients with advanced non-small-cell lung cancer: Outcomes from a randomized phase II trial (ModuLung)

Presented at ESMO 2019

28 September 2019

Approaches to Advance Cancer Vaccines to Clinical Utility

An M. T. Van Nuffel, Caroline Boudousquié, Sandra Tuyaerts (2019) - Editorial: Approaches to Advance Cancer Vaccines to Clinical Utility. Front. Immunol. 10:2032. doi: 10.3389/fimmu.2019.02032

28 August 2019

Lydie Meheus appointed to EMA’s Committee for Advanced Therapies (CAT)

30 July 2019